Myriad Genetics Balance Sheet Health
Financial Health criteria checks 4/6
Myriad Genetics has a total shareholder equity of $783.2M and total debt of $38.5M, which brings its debt-to-equity ratio to 4.9%. Its total assets and total liabilities are $1.1B and $363.3M respectively.
Key information
4.9%
Debt to equity ratio
US$38.50m
Debt
Interest coverage ratio | n/a |
Cash | US$140.90m |
Equity | US$783.20m |
Total liabilities | US$363.30m |
Total assets | US$1.15b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0K3W's short term assets ($313.6M) exceed its short term liabilities ($155.9M).
Long Term Liabilities: 0K3W's short term assets ($313.6M) exceed its long term liabilities ($207.4M).
Debt to Equity History and Analysis
Debt Level: 0K3W has more cash than its total debt.
Reducing Debt: 0K3W's debt to equity ratio has reduced from 25.7% to 4.9% over the past 5 years.
Debt Coverage: 0K3W's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 0K3W's interest payments on its debt are well covered by EBIT.